Journal of Cardiovascular Disease Research
THE STUDY OF SERUM PCSK9 IN CHRONIC KIDNEY DISEASE
Dr. Alka Puria, Dr. Sude Kumar Singh, Dr. Richa Raj, Dr. Ekram Goyal, Dr. Ajay Kumar, Dr. Surinder Kumar
JCDR. 2023: 2151-2158
Abstract
Chronic Kidney Disease (CKD) is associated with abnormal kidney function and a progressive decline in GFR ≤ (60ml/min/1.73m2) and irreversible reduction in nephrons. PCSK-9 (Proprotein convertase subtilisin/kexin type 9) is a new biomarker which has been observed to be raised in CKD patients
» PDF